Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARA: Ablation vs antiarrhythmic drugs in persistent atrial fibrillation
2008-006095-30Phase 4Active
- Sponsor
- Dr. Lluis Mont-Girbau
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of flecainide, amiodarone and propafenone in Atrial fibrillation (AFib) (2 arms), sponsored by Dr. Lluis Mont-Girbau. Primary endpoint: Absence of recurrent persistent atrial fibrillation or atrial flutter. Started Dec 2008; status: active.
02
Drugs
flecainideamiodaronepropafenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2008-006095-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006095-30.